Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Cocrystal Pharma, Inc. Common Stock (COCP)

Pharmaceutical Preparations

https://www.cocrystalpharma.com

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

19805 N. CREEK PARKWAY
BOTHELL, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/12/2018

Market Cap

18,200,928

Shares Outstanding

10,170,000

Weighted SO

10,173,790

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

ZIVO --.--%

RNXT --.--%

TPST --.--%

IKNA --.--%

CBIO --.--%

MBRX --.--%

PULM --.--%

CYCC --.--%

AKTX --.--%

Beta

1.4090

Last Div

0.0000

Range

1.33-3.24

Chg

0.0790

Avg Vol

32972

Mkt Cap

18200928

Exch

NASDAQ

Country

US

Phone

786 459 1831

DCF Diff

-0.7564

DCF

2.5464

Div Yield

0.0000

P/S

126.3953

EV Multiple

-0.0722

P/FV

1.0467

Div Yield %

0.0000

P/E

-1.0152

PEG

-0.0166

Payout

0.0000

Current Ratio

7.4077

Quick Ratio

7.4077

Cash Ratio

6.8644

DSO

2729.8958

DIO

0.0000

Op Cycle

2729.8958

DPO

2565.3024

CCC

164.5934

Gross Margin

-0.7222

Op Margin

-136.9097

Pretax Margin

-124.5000

Net Margin

-124.5000

Eff Tax Rate

0.1065

ROA

-0.8310

ROE

-0.7389

ROCE

-1.0421

NI/EBT

1.0000

EBT/EBIT

0.9094

EBIT/Rev

-136.9097

Debt Ratio

0.0825

D/E

0.1024

LT Debt/Cap

0.0808

Total Debt/Cap

0.0929

Int Coverage

-9857.5000

CF/Debt

-7.6888

Equity Multi

1.2405

Rec Turnover

0.1337

Pay Turnover

0.1423

Inv Turnover

0.0000

FA Turnover

0.0764

Asset Turnover

0.0067

OCF/Share

-1.3452

FCF/Share

-1.3517

Cash/Share

1.7906

OCF/Sales

-95.0424

FCF/OCF

1.0049

CF Coverage

-7.6888

ST Coverage

-54.5263

CapEx Coverage

-205.8294

Div&CapEx Cov

-205.8294

P/BV

1.0467

P/B

1.0467

P/S

126.3953

P/E

-1.0152

P/FCF

-1.3235

P/OCF

-1.3299

P/CF

-1.3299

PEG

-0.0166

P/S

126.3953

EV Multiple

-0.0722

P/FV

1.0467

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation